Pangea Therapeutics is transforming precision oncology through a powerful computational platform that makes sense of exome-wide genetic interactions. Using that approach, Pangea has developed accurate biomarkers that predict response and resistance to targeted therapies based on individual multiomic data. Pangea is working with leading cancer centers, pharma and biotech companies to improve clinical outcomes and develop the next generation of biomarker-guided therapies.
We are currently expanding and have several openings in our Tel Aviv-based R&D team. Please send CVs to firstname.lastname@example.org :